ArticlePloS one2024
Metabolic syndrome and related factors in Cameroonian women under contraceptive use.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathophysiological Consequences Associated with Hormonal Contraceptives Use in Sub-Saharan Africa: A Scoping Review.Open access journal of contraception · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesContraceptive is a device or drug that prevents a woman from becoming pregnant. Some types of contraceptive can cause a myriad of secondary effects such as overweight, increase of blood pressure triglycerides, and glucose intolerance. The combination of these secondary effects could, in the long term, develop metabolic syndrome in these women. The purpose of this study was to determine the prevalence of metabolic syndrome and related factors in Cameroonians women on contraceptives.
methodsThis was a cross-sectional study that included 231 Cameroonians fasting women from 18 to 49 years of age, on contraceptives. Sociodemographic, lifestyle, anthropometric and biochemical characteristics were collected. Metabolic syndrome was diagnosed using the criteria of the National Cholesterol Education Program- Adult Treatment Panel III. After validation of the data, statistical analysis was performed using Epi-Info software version 7.2.2.16 and the statistical level of significance was set at 5.0%.
results231 were using a modern contraceptive method, 28 were not using a contraceptive method, and 12 were non-consenting. The contraceptive method use rate was 89.19% and the most commonly used method was injectable contraception (49.35%). According to National Cholesterol Education Program criteria, almost 38.96% of these women were overweight and 50.65% had a serum high density lipoproteins cholesterol level of less than 0.50 g/L. Among women on contraceptives, the prevalence of metabolic syndrome was 22.08%. However, there was no significant association between contraceptive use and the occurrence of metabolic syndrome (p = 0.63).
conclusionContraceptive use was certain in all the participants, it's reported that, according to the NCEP-ATPIII a prevalence of 22.08% of metabolic syndrome among women using modern contraceptive methods in Douala, Republic of Cameroon. The high-risk groups were women using injectable method. Therefore, lipid profiles should be assessed in those women in order to manage them better.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.